What is the main purpose of this 10-Q/A filing?

This filing is an amendment to UnitedHealth Group's (UNH) previous 10-Q report for the period ending June 29, 2003. Its primary purpose is to provide additional exhibits, including amendments to a key Pharmacy Benefit Management Agreement, and to report on specific corporate actions and compliance matters like Sarbanes-Oxley certifications.

What was the stock split mentioned in the filing?

The company announced a two-for-one stock split in the form of a 100 percent common stock dividend, which was issuable on June 18, 2003, to shareholders of record on June 2, 2003. This means existing shareholders would have received one additional share for every share they owned.

Are there any financial performance details in this filing?

This specific filing (10-Q/A) is an amendment focused on exhibits and specific corporate disclosures rather than a comprehensive presentation of the company's financial performance for the period. While it references the period ending June 29, 2003, detailed financial statements and operational results are typically found in the original 10-Q filing.

What is the significance of the redacted portions of Exhibit 10?

Exhibit 10 details amendments to a Pharmacy Benefit Management Agreement with Merck Medco Managed Care, LLC. The redaction of confidential portions, filed separately with the SEC under a request for confidential treatment, indicates that specific terms, pricing, or operational details within this agreement are considered proprietary and not for public disclosure.

UNH 10-Q Quarterly Report Q2 FY2003 — Revenue, Net Income, EPS

Summary

This filing is an amendment to UnitedHealth Group Inc.'s (UNH) 10-Q report for the period ending June 29, 2003, filed on January 19, 2004. The primary purpose of this amendment appears to be the inclusion of specific exhibits and the reporting of material events during the quarter. Investors should note the filing of amendments to a significant Pharmacy Benefit Management Agreement with Merck Medco Managed Care, LLC, though confidential portions have been redacted. Additionally, the filing confirms the company's compliance with Sarbanes-Oxley Act certifications. Key events disclosed include a two-for-one stock split announced in May 2003, effective in June 2003, which would have doubled the number of outstanding shares and halved the par value. The company also reported on investor communications made during the quarter. While this filing focuses on exhibits and specific disclosures rather than detailed financial performance for the period, it provides important context regarding contractual agreements and corporate actions during the covered quarter.

Key Highlights

1Amendment to the 10-Q filing for the period ending June 29, 2003, filed on January 19, 2004.
2Filing includes amendments to the Pharmacy Benefit Management Agreement with Merck Medco Managed Care, LLC, with confidential portions redacted.
3Exhibit 31 confirms the filing of Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4Company announced a two-for-one stock split (100% stock dividend) effective June 18, 2003.
5Form 8-K filings reported on the stock split and investor presentations during the quarter.
6Key executives Stephen J. Hemsley (President and COO) and Patrick J. Erlandson (CFO and CAO) signed the filing.
7The filing emphasizes corporate governance and significant contractual agreements rather than detailed financial results for the period.

UNITEDHEALTH GROUP INC Quarterly Report (Amendment) for Q2 Ended Jun 30, 2003

Summary

Key Highlights

Frequently Asked Questions